SABBY 13G ABIO 8.08.12

Company

Oruka Therapeutics, Inc.

Filed

August 8, 2012

Accession Number

0001535610-12-000011

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →